1 5-Lipoxygenase (5-LO) catalyzes the initial steps in the formation of leukotrienes (LTs), which are implicated in immune reactions. Recently, it was shown that FITC-triggered epidermal Langerhans cell (LC) emigration to draining lymph nodes (LNs) is impaired in LTC 4 export pump (multidrug resistance-associated protein 1)-deficient mice. Here, we sought genetic evidence for a role of endogenous LTs in dendritic cell function through the study of 5-LO-deficient mice. Though DC numbers in skin, spleen, and peripheral LNs were similar in both 5-LO-deficient and wild-type (WT) mice, DC homing from skin to draining LNs induced by FITC was reduced by 75% in 5-LO-deficient mice. Moreover, in WT mice, all epidermal LCs, dermal langerin þ LCs, and subsets of dermal macrophages and langerin þ LCs in T-cell areas of skin-draining LNs markedly expressed 5-LO. However, the enzyme was noticeably absent in all DC subsets of the dermis, thymus, spleen, Peyer's patches, mesenteric LNs, and mucosal surfaces of lung and intestine. As all epidermal cells other than LCs lacked 5-LO and because differentiation and activation of DCs generated from 5-LO-deficient mice in vitro were normal, these data support a selective role of endogenous LTs in DC homing following skin sensitization.
INTRODUCTION 5-Lipoxygenase (5-LO) initiates synthesis of leukotrienes (LTs) which are implicated in innate and adaptive immune responses (Samuelsson et al., 1987; Funk, 2001) . 5-LO is expressed in most human leukocytes that participate in inflammation and the enzyme is also present in human leukocytes that regulate adaptive immunity including dendritic cells (DCs) such as epidermal and mucosal Langerhans cells (LCs) (Spanbroek et al., 1998) , lymph node (LN), and tonsil-interdigitating DCs, and germinal center mantle zone B cells, whereas T cells in secondary lymphoid organs lack 5-LO (Spanbroek et al., 2000) . Moreover, CD34
þ progenitors from human umbilical cord blood acquire constituents of the 5-LO pathway during DC differentiation and activation and are capable of generating LTs (Spanbroek et al. 2000 (Spanbroek et al. , 2001 . Despite these extensive data on human leukocytes, much less is known about 5-LO expression in mice. Though several mouse leukocytes of myeloid origin that regulate innate immune responses have been shown to express 5-LO (Chen et al., 1995; Murakami et al., 1995; Zhao et al., 2004) , nothing is known about its expression in leukocytes that participate in adaptive immunity such as DCs, T, or B cells. Indeed, most studies that sought to determine the role of LTs in adaptive immunity in mice have relied on functional assays using 5-LO-or LT receptor (LT-R)-deficient mice, but the LT-forming cells in these experimental settings have not been identified (Chen et al., 1994; Goulet et al., 1994; Bailie et al., 1996; Byrum et al., 1999; Goodarzi et al., 2003; Ott et al., 2003; Tager et al., 2003; Okunishi et al., 2004) . Circumstantial evidence indicated that LTs may determine LC migration to draining LNs. Mice deficient in the LTC 4 export pump multidrug resistance-associated protein 1 (MRP1) showed attenuated LC homing that was restored after intradermal application of LTC 4 (Robbiani et al., 2000) . These data raised the intriguing possibility that the MRP1 phenotype was due to the inability of the LCs to pump cysteinyl LTs from their intracellular sites of synthesis to the extracellular milieu. However, as MRP1 is not specific for LTs but exports a variety of intracellular mediators containing glutathione adducts (Konig et al., 1999) , involvement of molecules other than LTs in the MRP1 LC phenotype could not be ruled out.
Here, we examined the role of endogenous LTs in mice addressing several questions: Which DC and macrophage subsets express 5-LO? Are endogenous LTs regulators of LC migration? Do in vitro-generated DCs from 5-LO-deficient mice show normal growth, differentiation, and activation potentials, and do they respond to LTs? Our data reveal a strikingly selective expression of 5-LO in skin LCs and their emigrated counterparts in draining LNs. Moreover, both LC and dermal DC homing is markedly impaired in 5-LOdeficient mice though their DC differentiation and activation responses are normal. As LCs translocated 5-LO to the nuclear envelope in response to FITC activation in vivo and DCs translocated 5-LO to the nuclear membrane in response to lipopolysaccharide (LPS) in vitro, these data support a selective role of LC-derived LTs in skin immunity.
RESULTS

5-LO expression in mouse skin
Immunofluorescence analyses of wild-type (WT) epidermis for 5-LO, CD11c, and major histocompatability complex No apparent morphological alterations or changes in cell density were observed in LCs of 5-LO-deficient mice (see below). 5-LO in the dermis was restricted to MHC-II þ cells (Figure 1m-p) though not all MHC-II þ dermal cells expressed 5-LO. As Dupasquier et al. (2004) had shown that skin macrophages express MHC-II but not CD11c, we sought to distinguish the enzyme's expression in dermal DCs and dermal macrophages. For this purpose, we used colocalization experiments of 5-LO, CD11c, and langerin (Figure 1q-t) . These analyses revealed 5-LO þ / langerin þ /CD11c þ triple-positive DCs (Figure 1t ). These To examine whether peripheral tissue DC subsets and/or macrophages express 5-LO, trachea and small intestine were analyzed. In contrast to skin, 5-LO positivity was noticeably absent from CD11c þ cells in the epithelium and the subepithelial tissue compartments of trachea or intestine ( Figure S1 ). Yet, several 5-LO þ leukocytes were identified as either tissue macrophage subsets: Figure S1 and data not shown). Besides peripheral tissue DCs, several other DC subpopulations are present in primary and secondary lymphoid organs, that is, thymus, spleen, Peyer's patches, and LNs. To identify 5-LO-expressing DCs, we double-stained these tissues for CD11c and 5-LO. However, no CD11c þ cells could be observed in thymus, spleen, Peyer's patches, or mesenteric LNs (Figure 2a-d ; data not shown). As LCs were strongly 5-LO þ we examined skindraining LNs using DC subset marker antisera. To identify LCderived DCs in cutaneous LNs, combinations of CD11c, CD8a, CD205, and langerin antisera were used with 5-LO antisera (Figure 2e-t) . CD11c þ /5-LO þ DCs expressed CD8a or CD205 and are located in the T-cell areas of the paracortex of skin-draining LNs but, as mentioned above, none of the DC subsets of mesenteric LNs expressed 5-LO (Figure 2a-d) . This markedly selective staining pattern and localization (Inaba et al., 1997; Shortman and Liu 2002) www.jidonline.org 3 S Doepping et al.
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langerin þ double-positive LCs in draining LNs (Figure 2 q-t). These data revealed that no marker-discernable DC subsets in lymphoid organs other than LCs express 5-LO under steadystate conditions. However, other 5-LO þ cells were observed in lymphoid organs. These were rare Gr-1 þ polymorphonuclear granulocytes in thymus, spleen, and LNs and frequent CD68 þ capsular region macrophages ( Figure S2 and data not shown). In contrast to peripheral tissue macrophages and capsular region macrophages, lymphoid tissue macrophages (CD68 þ macrophages of spleen and LNs and MOMA-1 þ metallophilic spleen macrophages) lacked 5-LO ( Figure S2 ). When taken together, these data showed that LCs and LC-derived DCs in skin-draining LNs are strongly 5-LO þ , that all other DC subsets lacked 5-LO, and that distinct peripheral tissue and lymphoid organ macrophage subsets expressed 5-LO.
5-LO regulates homing of skin DCs to draining LNs following contact sensitization by FITC
To determine whether the 5-LO pathway affects LC and lymphoid organ DC densities under steady state conditions, we first examined LC and DC numbers of WT-and 5-LOdeficient mice of the epidermis, spleen, and peripheral LNs.
MHC-II
þ LCs of the epidermis ( Figure 3a ) and FACS analyses of isolated CD11c þ /MHC-II þ DCs of peripheral LNs and spleen ( Figure 3b ) revealed no substantial differences in numbers, distribution, and apparent morphologies of LCs and DCs. These data showed that LC and other DC subset densities under steady-state conditions are unaffected by 5-LO. To examine whether 5-LO plays a role during LC activation and skin sensitization, we applied FITC to abdominal and ear skins of WT-and 5-LO-deficient mice. Though FITC painting did not apparently affect emigration of LCs out of the epidermis (Figure 3a) and 5-LO expression in skin or recruited additional 5-LO þ cells into skin, quantification of CD11c þ /FITC þ DCs in draining LNs showed a marked DC migration defect in 5-LO-deficient mice that amounted to approximately 75% in five independent experiments ( Figure 3c ). To distinguish between LCs and dermal DCs, we examined langerin þ /FITC þ LCs and CD11c þ / FITC þ cells at 18 hours after FITC painting. We observed that both FITC þ skin DC populations (langerin þ and langerin À ) were present in draining LNs and that the majority of the cells were dermal langerin À DCs at this time point ( 
5-LO expression and cellular localization in in vitro differentiated DCs and LCs in vivo
Detailed molecular studies of growth properties and differentiation of primary DCs isolated from tissues ex vivo are difficult to perform. We generated DCs in vitro from bone marrow progenitors of 5-LO-deficient and WT mice. FACS analyses confirmed similar growth properties (data not shown) and 495% CD11c þ DCs after 14 days of culture in both genotypes. In addition, FACS analyses of CD11
þ DCs regarding the expression of MHC-II, CD8a, CD40, CD80, CD11b, and CD205 revealed no differences between the two genotypes ( Figure 4a) . Moreover, addition of LPS or tumor necrosis factor-a for 1-2 consecutive days induced cell maturation as shown by an increase of CD11c
þ DCs independent of the 5-LO genotype ( Figure 4 ; data not shown) though neither LPS nor tumor necrosis factor-a induced 5-LO as judged by real-time PCR and immunofluorescent analyses (not shown). However, similar to LCs in vivo and unlike DC subsets in peripheral organs in vivo, the majority of in vitro-generated DCs expressed 5-LO (Figure 5a-d) . These results resembled our earlier studies of human CD34 þ hematopoietic progenitor cell-derived DCs (Spanbroek et al., 2000) . We next stimulated in vitro-differentiated DCs with 100 nM LTD 4 or 100 nM LTB 4 www.jidonline.org 5 the predominant cysLT-R subtype of these DCs ( Figure S3b ). When taken together, these data provided evidence against an indispensable role of LTs in DC growth and differentiation and indicated that DCs in vitro retain the ability to upregulate 5-LO expression in response to extracellular factors and that they respond to both LTB 4 and LTD 4 . Subcellular localization in the cytosol and nucleus of 5-LO have been associated with the capacity to synthesize LTs in leukocytes of various origins (Peters-Golden and Brock, 2001). To clarify whether DC activation and final maturation induced translocation of 5-LO to the nuclear envelope, we localized 5-LO before and after activation of in vitro-differentiated DCs with LPS. 5-LO was evenly present in the nucleus throughout the nucleoplasm without apparent preference for the nuclear envelope in unstimulated DCs (Figure 5a-d) . Following activation with LPS for 1 day, marked translocation of 5-LO to the nuclear envelope had occurred (Figure 5e -h). More importantly, similar effects were observed in FITC-treated epidermal LCs. 5-LO localized in both the LC cytosols including the DCs, dendrites and nucleus in quiescent skin (Figure 5i-l) . However, 18 hours after FITC painting, translocation of cytosolic 5-LO to the nucleus had occurred as indicated by strong nuclear labeling and the disappearance of 5-LO positivity from the LCs dendrites (Figure 5m-p) . These data indicated that FITC activation of LCs or LPS activation of DCs stimulates LT formation by 5-LO translocation in vitro and in vivo.
DISCUSSION
Data detailed above can be summarized as follows: 5-LO expression in mouse DCs is restricted to LCs, subsets of dermal DCs, and skin-derived DCs of skin-draining LNs; tissue DC density and phenotypes are regulated independently of the 5-LO pathway in vivo under steady-state conditions; growth properties and DC marker expression of 5-LO-deficient DCs in vitro are comparable with those of WT mice; LC and dermis DC activation-dependent migration to skin-draining LNs is impaired in 5-LO-deficient mice; DCs generated from bone marrow progenitors in vitro express 5-LO and respond to LTB 4 and LTD 4 ; and 5-LO translocates to the nuclear envelope in LCs in vivo activated by FITC and in in vitro-generated DCs activated by LPS; like DCs tissue macrophage subsets show a restricted 5-LO expression pattern. When taken together, these data provide genetic evidence for a role of LTs in skin DC immunity. A major findings of this study is the markedly selective 5-LO expression in LCs, their dermal and skin-draining LN counterparts and distinct tissue macrophage subsets under steady-state conditions when compared to the corresponding human DC subsets (Spanbroek et al. 1998 (Spanbroek et al. , 2000 (Spanbroek et al. , 2001 . Moreover, in contrast to human germinal center mantle zone B cells and tingible body macrophages, the corresponding mouse cells lack 5-LO (Spanbroek et al. 2000 ; data not shown). Another major result of our study is genetic evidence that LTs are endogenous regulators of skin DC migration in mice. They provide strong support for the conclusion of Robbiani et al. (2000) that the LC migration defect observed in MRP1-deficient mice may be, at least in part, owing to the inability of these LCs to export cysLTs; moreover, we observe here that mouse lung DCs lack 5-LO and, interestingly, lung DC migration was recently reported to be normal in MRP1-deficient mice (Jakubzick et al., 2006) . The mechanisms underlying the striking skin DC migration defect could conceivably be located in the skin dermal cords and involve several mechanisms: The finding that FITC þ DCs in draining LNs is not restricted to langerin þ LCs but also observed in 5-LO À dermal DCs -within the time window examined here -is consistent with both an autocrine action of LTC 4 on LCs and a paracrine action of LTC 4 on dermal DCs. The latter mechanism would involve LC-derived or dermal macrophage-derived LTC 4 before/during the skin DCs enter lymphatic vessels. However, the precise mechanisms of LT effects and their corresponding downstream events could conceivably involve prostaglandins as 5-LO deficiency has been associated with overproduction of prostaglandins (Funk, 2001) , because PGD 2 has been shown to inhibit DC migration (Hammad et al., 2003) , and PGE 2 was demonstrated to promote DC migration through EP4 (Kabashima et al., 2003) . Our data also indicate the need to reinvestigate the role of the 5-LO pathway in contact sensitivity. Thus, Goulet et al. (1994) and Byrum et al. (1999) had failed to observe effects of 5-LO in contact sensitivity but noted that the FITC painting system may provide a (too) large excess of antigen to skin and that probably lower concentrations of FITC would uncover a role of LTs in contact sensitivity.
Though skin DC 5-LO expression was markedly restricted to LCs under steady-state and FITC-painting conditions, our in vitro data are consistent with the possibility that DC 5-LO may be subject to upregulation in different tissue environments: 5-LO is strongly expressed in in vitro-generated DCs raising the possibility that 5-LO may be subject to upregulation in DCs other than LCs under conditions of inflammation and/or ongoing immune responses in vivo. Thus, it may be of interest to examine the inducibility of the mouse 5-LO pathway after triggering DC-activating immune responses, infection, or inducing other types of inflammatory tissue reactions in which DCs participate.
Our in vivo and in vitro data do not support a major role of the 5-LO pathway in DC growth and differentiation. Indeed, the similar growth properties and phenotypes of WT-and 5-LO-deficient DCs in vitro are consistent with the conclusion of van de Ven et al. (2006) that the defective DC differentiation pathway that they had observed following inhibition of MRP1 could not be reversed by LTs (van de Ven et al. 2006 ). When we analyzed MHC-II or CD80 in FITC þ migrated DCs in draining LNs of WT and 5-LO-deficient mice, no significant alterations were observed. In addition, the densities and apparent morphologies of DCs in vivo appeared to be independent of 5-LO. When taken together, all these data indicate that the 5-LO pathway does not affect DC growth or DC maturation.
Cytosolic to nuclear envelope translocation of 5-LO in various unstimulated and activated human and mouse leukocytes has been associated with inactive or activated 5-LO and/or LT synthesis, respectively (Peters-Golden and Brock, 2001) . That FITC activation of skin DCs in vivo or LPS activation of DCs in vitro led to a marked translocation of 5-LO to the nuclear envelope indicates ongoing LT synthesis under conditions of skin hypersensitivity reactions in vivo and DC activation in vitro. Whether DC-derived or macrophagederived LTs act in autocrine and/or paracrine ways and which LTRs are involved in these actions remain important questions for future studies. The similar phenotypes of MRP1-and 5-LO-deficient mice regarding LC migration would favour selective cysLT action and the cysLT 1 -R in regulating LC migration.
MATERIALS AND METHODS
Mice 5-LO-deficient mice on the C57BL/6 background were a generous gift of Beverly Koller (Goulet et al., 1994) . WT mice were purchased from the Jackson Laboratory (Bar Habor, ME). Mice were housed in specific pathogen-free animal barrier facilities and used between 8 and 16 weeks. All experiments were approved by the Animal Ethics Committee of the Friedrich-Schiller-University of Jena, Jena, Germany.
DC preparations from lymphoid organs
Spleen and peripheral (pooled axillary, brachial, and inguinal) LNs were collected and single-cell suspensions were prepared by digestion of teased spleen and LN fragments at 371C for 30 minutes in RPMI 1640 supplemented with 10% heat inactivated fetal calf serum (FCS) and 1 mg/ml collagenase type D (Roche, Mannheim, Germany) followed by gentle pressing through a 30 mm cell strainer (Miltenyi Biotech GmbH, Bergisch Gladbach, Germany) . Spleen cells were resuspended for 3 minutes at room temperature in ammonium chloride to lyse residual erythrocytes. Finally, cells were washed and resuspended in phosphate-buffered saline supplemented with 2% FCS.
Flow cytometry
For FACS analyses, cells were treated with Fc-receptor blocking antibodies CD16/32 (clone 2.4G2; BD Biosciences, Heidelberg, Germany) for 15 min in phosphate-buffered saline supplemented with 2% FCS and 0.02% sodium azide (wash buffer). After blocking unspecific binding sites, cells were incubated with appropriate antibodies for 30 minutes followed by two washes in wash buffer. For FACS analyses with unlabeled primary antibodies, cells were treated with phycoerythrin-or FITC-coupled secondary antibodies for 30 minutes. FACS analyses were performed on a FACSCalibur instrument and results were analyzed with CellQuest software (BD Biosciences). The following antibodies were used for phenotypic analyses: CD8a (clone 53-6.7), CD11b-FITC (clone M1/70), CD11c-PE (clone HL3), CD40 (clone 3/23), and CD80-PE (clone 16-10A1) www.jidonline.org 7 S Doepping et al. 
Confocal laser scan microscopy
For immunofluorescence analyses, ears were separated with forceps into dorsal and ventral halves. To separate epidermis from dermis, dorsal halves were incubated for 45 minutes at 371C in phosphatebuffered saline supplemented with 2% FCS and 20 mM EDTA. Epidermal and dermal sheets and tissue cross sections (8 mm) were placed on glass slides and fixed with acetone for 10 minutes at 41C. After rehydration in phosphate-buffered saline supplemented with 2% FCS for 20 minutes at room temperature, specimens were incubated with rabbit anti-mouse 5-LO antiserum as described (Zhao et al. 2004) and for double or triple immunofluorescence analyses with unlabeled primary antibodies against B220 (clone RA3-6B2), CD3e (clone 17A2), CD8a (clone 53-6.7), CD11c (clone HL3), GR-1 (clone RB6-8C5), and I-A/I-E (clone 2G9) (Becton Dickinson, Heidelber, Germany) and antibodies against CD68 (clone FA11), CD205 (clone NLDC-145), F4/80 (clone CI:A3-1), and mouse metallophilic macrophages (clone MOMA-1) (Serotec, Dü sseldorf, Germany) and langerin (clone RMUL.2; eBioscience, San Diego, CA). Specimens were incubated for 45 minutes with secondary antibodies, that is, donkey anti-rat IgG-Cy5, goat anti-rat-Cy2, goat anti-hamster IgG-Cy5, and donkey anti-rabbit IgG-Cy3 (Dianova, Hamburg, Germany). Sheets were mounted on coverslips with Permafluor (Beckman, Munich, Germany) and viewed on a Zeiss Axiovert 200M microscope equipped with a confocal laser scanning head (LSM510). Pictures were taken and analyzed using LSM510 Image Examiner software (Zeiss, Jena, Germany).
Quantification of LC numbers in epidermal sheets
The density of LC in dorsal epidermal sheets from ear skin was determined either from untreated mice or 18 hours after FITC treatment using an objective lens of original magnification Â 40. Areas to be counted were selected for even staining and regular distribution of CD11c þ /MHC-II þ cells. Ten microscopic fields were randomly chosen for each individual experiment and four mice per group were used. Fields containing hair follicles were excluded from analyses. LCs were counted and medians and SEM were calculated.
FITC-induced in vivo migration of LCs
FITC treatment was performed as described earlier (Robbiani et al., 2000) . Briefly, mice were anesthetized and painted on dorsal sides of the ears and on shaved areas of neck and back with 25 ml of FITC (Isomer I, 8 mg/ml; Sigma-Aldrich, Deisenhofen, Germany) dissolved in dibutylphthalate (Sigma-Aldrich):acetone (1:1 
Generation of DCs from bone marrow progenitors
Bone marrow-derived cells were cultured in RPMI-1640 (Invitrogen, Leek, Netherlands), supplemented with 10% FCS (Bio Whittaker, Verviers, Belgium), 2 mM L-glutamine (Invitrogen), 50 mM 2-mercaptoethanol (Sigma-Aldrich), 10 mM N-2-hydroxyethylpiperazine-N 0 -2-ethanesulfonic acid, 1 mM sodium pyruvate, and 100 mg/ml penicillin/streptomycin (Invitrogen), referred to as complete medium. DCs were generated from bone marrow progenitors as described (Lutz et al., 1999) . Briefly, single-cell suspensions prepared from bone marrow were cultured in complete medium supplemented with GM-CSF (10 ng/ml R & D Systems, Wiesbaden-Nordenstadt, Germany). After 3 days, medium and nonadherent cells were removed and fresh complete medium with GM-CSF (10 ng/ml) was added. At day 13, nonadherent cells were considered to be immature DCs. For final maturation, DCs were cultured for the last 24 hours with LPS (100 ng/ml; Sigma-Aldrich). DC phenotypes were confirmed by CD8a, CD11b, CD11c, CD40, CD80, CD205, and MHC-II FACS analyses.
Quantitative real-time-PCR
Total RNA from isolated epidermis or from in vitro-generated DCs was extracted using the RNeasy kit (Qiagen, Hilden, Germany). Quantitative real-time-PCR was performed as reported 
Determination of intracellular free Ca
Cells were loaded with fura-2 acetoxymethyl ester (4 mmol/l; Calbiochem, Bad Soden, Germany) for 30 minutes at 371C in complete culture medium. After rinsing with calcium-buffer (145 mM NaCl, 5 mM KCl, 1 mM MgCl 2 , 1.5 mM CaCl 2 , 10 mM N-2-hydroxyethylpiperazine-N 0 -2-ethanesulfonic acid, 10 nM glucose, and 0.25% bovine serum albumin; pH adjusted to 7.4 using NaOH) the effects of LTB 4 and LTD 4 (100 nM; Cayman Chemicals, Ann Arbor, MI) on [Ca 2 þ ] i were determined using a fluorescence spectrometer LS50B and FL WinLab software (Perkin Elmer Applied Biosystems, Weiterstadt, Germany). Changes in [Ca 2 þ ] i were expressed as excitation ratios of 340/380 nm at 510 nm and calculated after background subtraction as described .
Statistical analysis
For statistical analyses Student's two-tailed paired t-tests were used. SUPPLEMENTARY MATERIAL Figure S1 . 5-LO-expressing cells in trachea and small intestine. Figure S2 . 5-LO expression in macrophage subsets and polymorphonuclear granulocytes of lymphoid organs. Figure S3 . Analyses of LTD4-induced [Ca2 þ ]i changes in bone marrowderived DCs and quantitative real-time-PCR analyses of LT-R mRNA expression in epidermal specimens and bone marrow-derived DCs.
